Skip to main content
Top
Published in: Archives of Virology 2/2018

01-02-2018 | Original Article

Early HIV infection among persons referred for malaria parasite testing in Nigeria

Authors: Babatunde A. Olusola, David O. Olaleye, Georgina N. Odaibo

Published in: Archives of Virology | Issue 2/2018

Login to get access

Abstract

Persons in the early stages of HIV infection are the major drivers of new infections. These individuals may also develop renal dysfunctions at this time. Nigeria, as other African countries, has one of the highest prevalence of newly diagnosed HIV infections. Despite this, limited information exists on early HIV detection in the continent. This may be related to difficulties in providing early HIV diagnosis and treatment. Patients referred for malaria testing may provide a unique opportunity for early HIV detection. In this study, a method for identifying early HIV-infected individuals was assessed. HIV-1 subtype and renal function biomarkers were also analyzed in these persons. To identify early HIV infection, over a period of 18 months blood samples were collected from persons referred by clinicians for malaria parasite tests in Nigeria. A total of 671 samples were collected and analyzed for HIV antigen/antibody and subtypes. 101 of these samples were categorized into one of four groups: early HIV, chronic HIV, malaria infection and control groups for renal function analysis. 29% of HIV infected individuals were at the early stages of infection. The predominant subtype detected was CRF02_AG (57.14%). The early HIV group had the highest mean serum creatinine (95 µmol/L) and urea (5.7 mmol/L) values across all groups with the difference significant at P < 0.05. There was no significant difference between the circulating subtype and the stage of HIV infection. Our results show the feasibility of screening persons referred for malaria tests for early HIV. This can be used to control new HIV infections in sub-Saharan Africa.
Literature
1.
go back to reference WHO (2014) WHO media centre fact sheet. World Health Organization, Geneva WHO (2014) WHO media centre fact sheet. World Health Organization, Geneva
3.
go back to reference Diallo K, Zheng D-P, Rottinghaus EK, Bassey O, Yang C (2015) Viral genetic diversity and polymorphisms in a cohort of HIV-1-infected patients eligible for initiation of antiretroviral therapy in Abuja, Nigeria. AIDS Res Hum Retrovir 31:564–575CrossRefPubMedPubMedCentral Diallo K, Zheng D-P, Rottinghaus EK, Bassey O, Yang C (2015) Viral genetic diversity and polymorphisms in a cohort of HIV-1-infected patients eligible for initiation of antiretroviral therapy in Abuja, Nigeria. AIDS Res Hum Retrovir 31:564–575CrossRefPubMedPubMedCentral
6.
go back to reference Lihana RW, Ssemwanga D, Abimiku A, Ndembi N (2012) Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev 14:83–100PubMed Lihana RW, Ssemwanga D, Abimiku A, Ndembi N (2012) Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev 14:83–100PubMed
8.
go back to reference Odaibo GN, Olaleye OD, Heyndrickx I, Vereecken K, Houwer K, Jassesn W (2006) Mother-to-child transmission of different HIV-1 subtypes among ARV Naïve infected pregnant women in Nigeria. Rev Inst Med Trop Sao Paulo 48:77–80CrossRefPubMed Odaibo GN, Olaleye OD, Heyndrickx I, Vereecken K, Houwer K, Jassesn W (2006) Mother-to-child transmission of different HIV-1 subtypes among ARV Naïve infected pregnant women in Nigeria. Rev Inst Med Trop Sao Paulo 48:77–80CrossRefPubMed
15.
go back to reference Cheret A, Durier C, Melard A et al (2017) Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS One 12:1–16CrossRef Cheret A, Durier C, Melard A et al (2017) Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS One 12:1–16CrossRef
16.
go back to reference Henn MR, Boutwell CL, Charlebois P et al (2012) Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 8:e1002529CrossRefPubMedPubMedCentral Henn MR, Boutwell CL, Charlebois P et al (2012) Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 8:e1002529CrossRefPubMedPubMedCentral
18.
go back to reference Ahlstrom MG, Feldt-rasmussen B, Gerstoft J et al (2016) Routine urine protein/creatinine ratio testing in an outpatient setting of Danish HIV-infected individuals. Infect Dis (Lond). doi:10.3109/23744235.2016.1154600 Ahlstrom MG, Feldt-rasmussen B, Gerstoft J et al (2016) Routine urine protein/creatinine ratio testing in an outpatient setting of Danish HIV-infected individuals. Infect Dis (Lond). doi:10.​3109/​23744235.​2016.​1154600
25.
go back to reference Brooks JT, Robbins KE, Youngpairoj AS et al (2006) Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS 20:923–928CrossRefPubMed Brooks JT, Robbins KE, Youngpairoj AS et al (2006) Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS 20:923–928CrossRefPubMed
26.
go back to reference Olaleye D (1996) Isolation and characterization of a new subtype A variant of human immunodeficiency virus type I from Nigeria. Trop Med Int Health 1996:97–106CrossRef Olaleye D (1996) Isolation and characterization of a new subtype A variant of human immunodeficiency virus type I from Nigeria. Trop Med Int Health 1996:97–106CrossRef
28.
go back to reference Montavon C, Toure-Kane C, Nkengasong J, Vergne L, Hertogs K, Mboup S, Delaporte E, Peeters M (2002) CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr 29:522–530CrossRefPubMed Montavon C, Toure-Kane C, Nkengasong J, Vergne L, Hertogs K, Mboup S, Delaporte E, Peeters M (2002) CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr 29:522–530CrossRefPubMed
29.
go back to reference Cohen MS, Dye C, Fraser C et al (2012) HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies? PLoS Med 9:e1001232CrossRefPubMedPubMedCentral Cohen MS, Dye C, Fraser C et al (2012) HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies? PLoS Med 9:e1001232CrossRefPubMedPubMedCentral
31.
go back to reference Rossenkhan R, Macleod IJ, Brumme ZL et al (2016) Transmitted/founder HIV-1 subtype C viruses show distinctive signature patterns in Vif, Vpr, and Vpu that are under subsequent immune pressure during early infection. AIDS Res Hum Retrovir. doi:10.1089/aid.2015.0330 PubMedPubMedCentral Rossenkhan R, Macleod IJ, Brumme ZL et al (2016) Transmitted/founder HIV-1 subtype C viruses show distinctive signature patterns in Vif, Vpr, and Vpu that are under subsequent immune pressure during early infection. AIDS Res Hum Retrovir. doi:10.​1089/​aid.​2015.​0330 PubMedPubMedCentral
32.
go back to reference Claiborne DT, Prince JL, Scully E et al (2015) Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad USA. doi:10.1073/pnas.1421607112 Claiborne DT, Prince JL, Scully E et al (2015) Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad USA. doi:10.​1073/​pnas.​1421607112
33.
go back to reference Gardner LI et al (2003) Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 32(2):203–209CrossRefPubMed Gardner LI et al (2003) Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 32(2):203–209CrossRefPubMed
35.
go back to reference Winston A, Kiotman E, Winston JA et al (1996) Are we missing an epidemic. J Am Soc Nephrol 7:1–7PubMed Winston A, Kiotman E, Winston JA et al (1996) Are we missing an epidemic. J Am Soc Nephrol 7:1–7PubMed
38.
go back to reference Martin DH, Pearson JE, Kumar P, Kirkendol PL, Leech SH, Gonzalez FM, Saxinger CSH (1991) Sequential measurement of beta 2-microglobulin levels, p24 antigen levels, and antibody titers following transplantation of a human immunodeficiency virus-infected kidney allograft. J Acquir Immune Defic Syndr 4:1118–1121PubMed Martin DH, Pearson JE, Kumar P, Kirkendol PL, Leech SH, Gonzalez FM, Saxinger CSH (1991) Sequential measurement of beta 2-microglobulin levels, p24 antigen levels, and antibody titers following transplantation of a human immunodeficiency virus-infected kidney allograft. J Acquir Immune Defic Syndr 4:1118–1121PubMed
Metadata
Title
Early HIV infection among persons referred for malaria parasite testing in Nigeria
Authors
Babatunde A. Olusola
David O. Olaleye
Georgina N. Odaibo
Publication date
01-02-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 2/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3599-3

Other articles of this Issue 2/2018

Archives of Virology 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.